PSI CRO AG

PSI CRO AG is a global contract research organization (CRO) specializing in clinical trial management, drug development services, and research solutions for pharmaceutical, biotechnology, and medical device companies. Founded in 1995 and headquartered in Zug, Switzerland, PSI provides comprehensive clinical research services designed to support the development of innovative healthcare products worldwide.

The company manages clinical studies across all phases of development, including Phase I–IV clinical trials, offering services such as clinical operations, patient recruitment, regulatory affairs, clinical data management, biostatistics, medical writing, pharmacovigilance, and laboratory coordination.

PSI has extensive experience across therapeutic areas including oncology, vaccines, infectious diseases, cardiology, dermatology, neuroscience, and rare diseases. The company operates specialized research teams and global clinical networks that help sponsors conduct efficient and high-quality clinical trials.

PSI CRO focuses on technology-enabled research approaches, utilizing digital tools, centralized monitoring, and advanced data management systems to improve clinical trial performance. Its patient-focused strategies help increase enrollment efficiency and enhance participant engagement throughout clinical studies.

The organization maintains a strong commitment to quality, compliance, and scientific excellence. PSI follows international clinical research standards, including Good Clinical Practice (GCP), ICH guidelines, FDA regulations, EMA requirements, and global quality management systems.

With operations across more than 60 countries and decades of clinical research expertise, PSI CRO has become a trusted partner for pharmaceutical and biotechnology companies seeking reliable clinical development solutions.

The company’s integrated approach helps accelerate the delivery of new medicines while maintaining patient safety, regulatory compliance, and research quality.